Paper1618554
Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses.
Ullian ME and 2 others. Hypertension, 1992. Cited by 124 papers, by iCite.
Cite this record
ConductScience Library. Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses. Papers, record 1618554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1618554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aldosterone | Major topic |
| Inositol Phosphates | Major topic |
| Receptors, Angiotensin | Major topic |
| Angiotensin II | |
| Animals | |
| Male | |
| Rats | |
| Rats, Inbred Strains |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DK-07135 | NIDDK NIH HHS | United States | T32DK007135 | PubMed and NIH | NIH RePORTER |
| DK-08064 | NIDDK NIH HHS | United States | F32DK008064 | PubMed and NIH | NIH RePORTER |
| DK-35098 | NIDDK NIH HHS | United States | P01DK035098 | PubMed and NIH | NIH RePORTER |
| P50DK035098 | NIH | NIH RePORTER |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33846799 | Role of the central renin‑angiotensin system in hypertension (Review). | Int J Mol Med | 2021 | https://conductscience.org/library/papers/33846799 | PubMed |
| 32865116 | Neurohormonal Regulation of IKs in Heart Failure: Implications for Ventricular Arrhythmogenesis and Sudden Cardiac Death. | J Am Heart Assoc | 2020 | https://conductscience.org/library/papers/32865116 | PubMed |
| 32128854 | Aldosterone and the mineralocorticoid receptor in renal injury: A potential therapeutic target in feline chronic kidney disease. | J Vet Pharmacol Ther | 2020 | https://conductscience.org/library/papers/32128854 | PubMed |
| 30806496 | The renin-angiotensin-aldosterone system and its suppression. | J Vet Intern Med | 2019 | https://conductscience.org/library/papers/30806496 | PubMed |
| 27122708 | Pharmacology of Aldosterone and the Effects of Mineralocorticoid Receptor Blockade on Cardiovascular Systems. | Acta Cardiol Sin | 2013 | https://conductscience.org/library/papers/27122708 | PubMed |
| 25009258 | The role of the hypothalamic paraventricular nucleus and the organum vasculosum lateral terminalis in the control of sodium appetite in male rats. | J Neurosci | 2014 | https://conductscience.org/library/papers/25009258 | PubMed |
| 23993726 | Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling. | Int J Cardiol | 2013 | https://conductscience.org/library/papers/23993726 | PubMed |
| 22475354 | Physiologic responses to severe hemorrhagic shock and the genesis of cardiovascular collapse: can irreversibility be anticipated? | J Surg Res | 2012 | https://conductscience.org/library/papers/22475354 | PubMed |
| 22087022 | Chronic angiotensin receptor blockade suppresses intracardiac angiotensin II in angiotensin II-infused rats. | Exp Biol Med (Maywood) | 2011 | https://conductscience.org/library/papers/22087022 | PubMed |
| 21949629 | Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control. | Integr Blood Press Control | 2010 | https://conductscience.org/library/papers/21949629 | PubMed |
| 21112947 | Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension. | Am J Physiol Heart Circ Physiol | 2011 | https://conductscience.org/library/papers/21112947 | PubMed |
| 20596805 | Aldosterone in the pathogenesis of chronic kidney disease and proteinuria. | Curr Hypertens Rep | 2010 | https://conductscience.org/library/papers/20596805 | PubMed |
| 19106220 | Endogenous aldosterone contributes to acute angiotensin II-stimulated plasminogen activator inhibitor-1 and preproendothelin-1 expression in heart but not aorta. | Endocrinology | 2009 | https://conductscience.org/library/papers/19106220 | PubMed |
| 15831601 | Pathophysiology of heart failure following myocardial infarction. | Heart | 2005 | https://conductscience.org/library/papers/15831601 | PubMed |
| 15053040 | The effects of low calcium dialysate on arterial compliance and vasoactive substances in patients with hemodialysis. | Korean J Intern Med | 2004 | https://conductscience.org/library/papers/15053040 | PubMed |
| 12140725 | Central role of the AT(1)-receptor in atherosclerosis. | J Hum Hypertens | 2002 | https://conductscience.org/library/papers/12140725 | PubMed |
| 8773261 | Molecular biology of angiotensin receptors and their role in human cardiovascular disease. | J Mol Med (Berl) | 1996 | https://conductscience.org/library/papers/8773261 | PubMed |
| 8770880 | Role of aldosterone in the remnant kidney model in the rat. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8770880 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1618554
GET https://conductscience.org/api/papers/v1/1618554/authors